{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-085391","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.768493+00:00","generated_at":"2026-05-31T13:32:57.443897+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Applied DNA Sciences special meeting fails due to lack of quorum; warrant approval deferred","bullets":["Special meeting on Aug 2, 2024 had 4,056,202 shares present, below required majority; adjourned without action.","Proposal sought stockholder approval to exercise Series A and B warrants from May 2024 public offering.","Without approval, company must call a subsequent meeting to seek warrant stockholder approval.","Series Warrants remain unexercisable until Nasdaq-required shareholder approval is obtained."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-085391","json":"https://secwatch.observer/filing/0001104659-24-085391.json","markdown":"https://secwatch.observer/filing/0001104659-24-085391.md","text":"https://secwatch.observer/filing/0001104659-24-085391.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465924085391/0001104659-24-085391-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465924085391/tm2420716d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:32:57.443897+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}